大博医疗最新公告：上半年净利润2.44亿元 同比增长76.69%

Core Insights - Dabo Medical (002901.SZ) reported a revenue of 1.21 billion yuan for the first half of 2025, representing a year-on-year growth of 25.55% [1] - The net profit attributable to shareholders reached 244 million yuan, marking a significant increase of 76.69% compared to the previous year [1] - The basic earnings per share stood at 0.60 yuan [1] Revenue Breakdown - The trauma product line generated revenue of 468 million yuan, reflecting a year-on-year growth of 23.68% [1] - The spinal product line achieved revenue of 217 million yuan, with a year-on-year increase of 29.86% [1]